PTX Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Prescient Therapeutics Ltd

Watchlist Manager

Watchlist

Price: 0.067 AUD Market Closed

Market Cap: AU$70.5m

	Prescient Therapeutics Ltd ASX:PTX	AU
	Mitra Pinasthika Mustika Tbk PT IDX:MPMX	ID
	Anima Holding SpA MIL:ANIM	IT
S	Subsea 7 SA DUS:SOC	UK
F	Fancy Wood Industries PCL SET:FANCY	TH
	Windlas Biotech Ltd NSE:WINDLAS	IN
	Target Group Inc OTC:CBDY	CA
I	InterDigital Inc F:IDI	US
	Brewbilt Manufacturing Inc OTC:BBRW	US

Profitability Summary

Prescient Therapeutics Ltd's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Low Gross Margin

Low 3Y Average Gross Margin

Negative Operating Margin

-25 420%

Negative 3Y Average Operating Margin

-6 420%

Declining Operating Margin

-1 538% > -25 420%

Negative Net Margin

-25 387%

Negative 3Y Average Net Margin

-6 468%

Declining Net Margin

-1 526% > -25 387%

Negative Free Cash Flow Margin

-22 915%

Negative 3Y Average Free Cash Flow Margin

-6 044%

Declining Free Cash Flow Margin

-1 349% > -22 915%

Negative ROE

-54%

Negative 3Y Average ROE

Negative 3Y Average ROIC

-148%

ROIC is Increasing

-156% > -118%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.